Wockhardt Revenue

Wockhardt had revenue of 8.09B INR in the quarter ending September 30, 2024, with 7.44% growth. This brings the company's revenue in the last twelve months to 29.81B, up 7.46% year-over-year. In the fiscal year ending March 31, 2024, Wockhardt had annual revenue of 28.30B with 6.51% growth.

Revenue (ttm)

29.81B

Revenue Growth

+7.46%

P/S Ratio

7.33

Revenue / Employee

12.49M

Employees

2,386

Market Cap

242.12B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	28.30B	1.73B	6.51%
Mar 31, 2023	26.57B	-5.73B	-17.74%
Mar 31, 2022	32.30B	5.22B	19.28%
Mar 31, 2021	27.08B	-1.36B	-4.78%
Mar 31, 2020	28.44B	-7.22B	-20.24%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Wockhardt News

9 days ago - Wockhardt shares surge over 4% on successful Zaynich treatment for drug-resistant infections - Business Upturn
6 weeks ago - Wockhardt shares jump 4% on Q2 FY25 results - Business Upturn
6 weeks ago - Workhardt Q2 FY25 Results: Revenue up 7.43% YoY to Rs 809 crore, Net Loss widens to Rs 22 crore - Business Upturn
6 weeks ago - Wockhardt Q2 FY25 results: Stock drops 3% ahead of result announcement - Business Upturn
2 months ago - Wockhardt files Insulin Aspart injection with DCGI, reinforcing diabetes management commitment - Business Upturn
2 months ago - Wockhardt’s WCK 6777 earns Fast Track Designation from USFDA - Business Upturn
3 months ago - Wockhardt founder Dr. Habil Khorakiwala honored with lifetime achievement award - Business Upturn
3 months ago - Wockhardt’s Zaynich™ treats drug-resistant meningitis in clinical case - Business Upturn

More News